Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
26,546,714
-
Shares change
-
-195,109
-
Total reported value, excl. options
-
$288,027,507
-
Value change
-
-$1,865,390
-
Number of buys
-
43
-
Number of sells
-
39
-
Price
-
$10.85
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2020
As of 31 Dec 2020 LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) had 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,546,714 shares of stock of the company.
Largest 10 holders included Legion Partners Asset Management, LLC, WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Russell Investments Group, Ltd., HEARTLAND ADVISORS INC, Cove Street Capital, LLC, INVESTMENT COUNSELORS OF MARYLAND LLC, and KENNEDY CAPITAL MANAGEMENT, INC..
This table shows 95 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.